Original Report

Racial disparities in breast cancer diagnosis in Central Georgia in the United States


 

Background Mortality rates in breast cancer are worse for African Americans than for whites.

Objective To investigate the presence of racial disparities in clinical staging in women diagnosed with breast cancer and understand whether such disparities exist in Central Georgia in the United States.

Methods We retrospectively reviewed records from the Tumor Registry of the Medical Center Navicent Health in Macon, Georgia, of women who had been diagnosed with breast cancer during 2011-2013. The chi-square test was used to assess statistically significant differences between whites and African Americans. We also assessed the patients’ health insurance status and age at diagnosis.

Results A total of 578 participants were identified. Statistically significant differences existed in the clinical stage between the races (P = .0003). Whites were more often clinical stage I at diagnosis, whereas African Americans had a greater percentage of stages II, III, or IV. African Americans were more than twice as likely to be diagnosed at clinical stage IV than were their white counterparts. Statistical differences also existed with age at diagnosis (P = .0066) and insurance coverage (P = .0004). A greater percentage of white patients were aged 65 years or older at diagnosis, whereas a greater percentage of African American patients were aged 49 years or younger. A greater percentage of African Americans had Medicaid insurance, whereas a greater percentage of whites had private health insurance.

Limitations As a single-center study, it is difficult to generalize these results elsewhere. Furthermore, this study focused on association and not on causation. It is difficult to pinpoint why such disparities exist.

Conclusion The etiology of racial disparities between African American and white women with breast cancer seems to be multifaceted. Screening mammography remains an important tool for identifying breast cancer. Low socioeconomic and educational status as well as a lack of a primary care physician may play a role in these disparities. Other factors that may have a role include biological factors and possible mistrust of the health care system.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

VIDEO: Time to skip chemo for luminal A tumors?
MDedge Hematology and Oncology
VIDEO: Estrogen receptor gene mutations linked to poorer survival
MDedge Hematology and Oncology
VIDEO: Beta-blocker prevented trastuzumab-related drop in LVEF
MDedge Hematology and Oncology
VIDEO: Is anastrozole or tamoxifen best for secondary prevention of DCIS?
MDedge Hematology and Oncology
VIDEO: Patient-reported outcomes differ by age with anastrozole versus tamoxifen for DCIS
MDedge Hematology and Oncology
VIDEO: TH3RESA results further solidify role of T-DM1
MDedge Hematology and Oncology
Oncology 2015: new therapies and new transitions toward value-based cancer care
MDedge Hematology and Oncology
Early infection-related hospitalization portends poor breast cancer prognosis
MDedge Hematology and Oncology
Statins don’t increase breast cancer risk
MDedge Hematology and Oncology
Cancer clinical trial enrollment of diverse and underserved patients within an urban safety net hospital
MDedge Hematology and Oncology